Lorazepam-induced effects on silent period and corticomotor excitability

Experimental Brain Research
V K KimiskidisK R Mills

Abstract

TMS studies on the CNS effects of benzodiazepines have provided contradictory results. The objective of this study is to describe the effects of lorazepam on silent period (SP) and corticomotor excitability. Twelve healthy male subjects (median age 35 years) were studied at baseline, following i.v. lorazepam administration and after reversal of the benzodiazepine effects with i.v. flumazenil. Lorazepam was given at a low-dose in one subject (0.0225 mg/kg bolus + 2 microg/kg/h infusion) and at a high-dose (0.045 mg/kg bolus + 2.6 microg/kg/h infusion) in the rest. Threshold (Thr) was measured at 1% steps. SPs were investigated with two complementary methods. First, SPs were elicited using a wide range of stimulus intensities (SIs) (from 5 to 100% maximum SI at 5% increments). At each SI, four SPs were obtained and the average value of SP duration was used to construct a stimulus/response (S/R) curve of SI versus SP .The resulting S/R curves were then fitted to a Boltzman function, the best-fit values of which were statistically compared for each experimental condition (i.e., baseline vs. lorazepam vs. flumazenil). Second, a large number of SPs (n=100) was elicited during each of the three experimental conditions using blocks of ...Continue Reading

References

Feb 1, 1992·Electroencephalography and Clinical Neurophysiology·K R MillsM Schubert
Jan 1, 1991·Intensive Care Medicine·A WeinbroumE Geller
Nov 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R E Study, J L Barker
Dec 1, 1994·Trends in Neurosciences·I ModyI Soltesz
Apr 1, 1996·Experimental Brain Research·U ZiemannW Paulus
Dec 1, 1996·Trends in Pharmacological Sciences·M Malcangio, N G Bowery
Dec 16, 1998·Electroencephalography and Clinical Neurophysiology·J MathisC W Hess
Sep 14, 1999·Journal of Neurophysiology·V Lopantsev, P A Schwartzkroin
Dec 2, 1999·Journal of the Autonomic Nervous System·A J VoogelG A van Montfrans
May 10, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·V Di LazzaroJ C Rothwell
Aug 31, 2000·Critical Care Medicine·D J GreenblattR I Shader
May 5, 2001·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·B BoroojerdiL G Cohen
Nov 19, 2002·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Babak Boroojerdi
Jan 28, 2004·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·V Di LazzaroJ C Rothwell
Jan 28, 2004·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·H Y JungM Hallett
Mar 24, 2004·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Alexander A FingelkurtsSeppo Kähkönen

❮ Previous
Next ❯

Citations

Feb 22, 2011·Psychopharmacology·Gionata StrigaroRoberto Cantello
Dec 3, 2008·Experimental Brain Research·J T H TeoJ C Rothwell
Feb 25, 2009·Journal of Neural Transmission·Xingbao LiMark S George
Oct 4, 2007·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Konrad J WerhahnSven Klimpe
Jan 23, 2016·Schizophrenia Research·Alanna C BridgmanTony P George
Oct 25, 2012·Brain Stimulation·Benjamin I Silbert, Gary W Thickbroom
Feb 22, 2012·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·S GroppaH R Siebner
Jun 30, 2009·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Christopher A RábagoPeter T Fox
Apr 1, 2009·Muscle & Nerve·Christian BinderJoachim Liepert
Sep 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Anne-Fleur van RootselaarMarina A J Tijssen
Jun 4, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Anna FuhlUlf Ziemann
Oct 15, 2013·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Danilo R de JesusZafiris J Daskalakis
Dec 24, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Ulf ZiemannFlorian Müller-Dahlhaus
May 16, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Annemarie HübersUlf Ziemann
Dec 18, 2013·Neuroscience Letters·Sharyl SamargiaTeresa Jacobson Kimberley
Mar 20, 2009·Seizure : the Journal of the British Epilepsy Association·Yasemin AkgunBaki Arpaci
Jul 30, 2016·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Annika A de GoedeMichel J A M van Putten
Apr 4, 2017·The European Journal of Neuroscience·J L NevaL A Boyd
Jun 27, 2008·The Journal of ECT·Rita NavarroDavid Avery
Jun 13, 2017·Neurorehabilitation and Neural Repair·Whitney A GrayMichael R Borich
Dec 28, 2017·Neuroreport·Kai-Hsiang Chen, Ying-Zu Huang
Aug 1, 2020·Frontiers in Neurology·Mario Stampanoni BassiEnnio Iezzi
Mar 29, 2014·Journal of Neurophysiology·Vasiliy E BuharinMinoru Shinohara
Dec 5, 2019·PloS One·Mustafa Görkem ÖzyurtKemal Sitki Türker
Apr 29, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Charles P LewisPaul E Croarkin
Jul 19, 2018·Brain Topography·Esther M Ter BraackMichel J A M van Putten
Jul 7, 2020·Clinical Therapeutics·Melissa TsuboyamaAlexander Rotenberg
Mar 25, 2021·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mélodie Proteau-LemieuxArtuela Çaku
Sep 25, 2020·Journal of Neuroscience Methods·K E HupfeldR D Seidler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.